EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tailored Combinations of Human Milk Oligosaccharides Modulate the Immune Response in an In Vitro Model of Intestinal Inflammation

Clodagh Walsh, Jonathan A Lane, Douwe van Sinderen, Rita M Hickey iD

Biomolecules · 21.11.2024 · 14 (12) · 1481

DOI: 10.3390/biom14121481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 21.11.2024. Verfasst von Clodagh Walsh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Teagasc Food Research Centre, Moorepark, Fermoy, P61 C996 Cork, Ireland. Hauptthemen laut MEDLINE: Milk, Human, Oligosaccharides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland, H and H Group, Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infants rely on their developing immune system and the protective components of breast milk to defend against bacterial and viral pathogens, as well as immune disorders such as food allergies, prior to the introduction of solid foods. When breastfeeding is not feasible, fortified infant formula will most frequently be offered, usually based on a cow’s milk-based substitute. The current study aimed to explore the immunomodulatory effects of combinations of commercially available human milk oligosaccharides (HMOs). An in vitro co-culture model of Caco-2 intestinal epithelial cells and THP-1 macrophages was established to replicate the hallmarks of intestinal inflammation and to evaluate the direct effects of different synthetic HMO combinations. Notably, a blend of the most prevalent fucosylated and sialylated HMOs, 2′-fucosyllactose (2′-FL) and 6′-siallylactose (6′-SL), respectively, resulted in decreased pro-inflammatory cytokine levels. These effects were dependent on the HMO concentration and on the HMO ratio resembling those in breastmilk. Interestingly, adding additional HMO structures did not enhance the anti-inflammatory effects. This research highlights the importance of carefully selecting HMO combinations in nutritional products, particularly for infant milk formulations, to effectively mimic the benefits associated with breastmilk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Milk, HumanOligosaccharidesHumansCaco-2 CellsInflammationCytokinesCoculture TechniquesMacrophagesTHP-1 CellsTrisaccharides

Stichwörter der Autor:innen

Caco-2HMONECbreastmilkimmunityinflammationprebiotics

Substanzen

Oligosaccharides2'-fucosyllactoseCytokinesTrisaccharides

Autor:innen und Institutionen

  • Teagasc Food Research Centre, Moorepark, Fermoy, P61 C996 Cork, Ireland.
  • Health and Happiness Group, H&H Research, P61 K202 Cork, Ireland.
  • APC Microbiome Ireland and School of Microbiology, University College Cork, T12 YT20 Cork, Ireland.

ORCID-Profile: Rita M Hickey

Förderung

  • Science Foundation Ireland
  • H and H Group, Ireland

Zitieren

APA

Walsh, C., Lane, J. A., van Sinderen, D., & Hickey, R. M. (2024). Tailored Combinations of Human Milk Oligosaccharides Modulate the Immune Response in an In Vitro Model of Intestinal Inflammation. Biomolecules, 14(12), 1481. https://doi.org/10.3390/biom14121481

Vancouver

Walsh C, Lane JA, van Sinderen D, Hickey RM. Tailored Combinations of Human Milk Oligosaccharides Modulate the Immune Response in an In Vitro Model of Intestinal Inflammation. Biomolecules. 2024;14(12):1481. doi:10.3390/biom14121481

BibTeX
@article{Walsh2024,
  author = {Walsh, Clodagh and Lane, Jonathan A and van Sinderen, Douwe and Hickey, Rita M},
  title = {Tailored Combinations of Human Milk Oligosaccharides Modulate the Immune Response in an In Vitro Model of Intestinal Inflammation},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {12},
  pages = {1481},
  doi = {10.3390/biom14121481}
}
Kostenlos starten →